← All Mutual Funds

FIDELITY ADVISOR SERIES VII

CIK: 0000315700 Equity
Report date: 2026-06-26
AUM $2.9B
Expense Ratio —
Category Equity
State MA
Fiscal Year End —
Inception Date —
Manager —
Latest Filing 2026-06-26

Holdings

From latest SEC N-PORT filing · US-listed stocks only

74 positions
# Security Name CUSIP Asset Type Weight % Value ($M) Quantity
1 UPB UPSTREAM BIO INC Since 2026-07-07 91678A107 Equity (Common)
0.13%
 $3.67 400,000
2 TMO THERMO FISHER SCIENTIFIC INC Since 2026-07-07 883556102 Equity (Common)
3.62%
 $104.41 218,000
3 SI SHOULDER INNOVATIONS INC Since 2026-07-07 82537J108 Equity (Common)
0.14%
 $3.97 310,692
4 DNTH DIANTHUS THERAPEUTICS INC Since 2026-07-07 252828108 Equity (Common)
0.26%
 $7.46 85,000
5 PRAX PRAXIS PRECISION MEDICINES INC. Since 2026-07-07 74006W207 Equity (Common)
0.59%
 $16.90 53,000
6 AXSM AXSOME THERAPEUTICS INC Since 2026-07-07 05464T104 Equity (Common)
0.81%
 $23.27 112,000
7 ABBV ABBVIE INC Since 2026-07-07 00287Y109 Equity (Common)
2.23%
 $64.24 304,000
8 PRVA PRIVIA HEALTH GROUP INC Since 2026-07-07 74276R102 Equity (Common)
1.02%
 $29.32 1,180,000
9 TRVI TREVI THERAPEUTICS INC Since 2026-07-07 89532M101 Equity (Common)
0.24%
 $6.88 500,000
10 CRNX CRINETICS PHARMACEUTICALS INC Since 2026-07-07 22663K107 Equity (Common)
0.90%
 $25.98 670,000
11 KMTS KESTRA MEDICAL TECHNOLOGIES INC Since 2026-07-07 N/A Equity (Common)
0.30%
 $8.70 420,000
12 DMRA DAMORA THERAPEUTICS INC Since 2026-07-07 36322Q206 Equity (Common)
0.25%
 $7.18 280,000
13 CYCN CYCLERION THERAPEUTICS INC Since 2026-07-07 N/A Equity (Common)
0.01%
 $0.34 138,700
14 IRON DISC MEDICINE INC Since 2026-07-07 254604101 Equity (Common)
0.79%
 $22.75 345,000
15 ALHC ALIGNMENT HEALTHCARE INC Since 2026-07-07 01625V104 Equity (Common)
0.84%
 $24.34 1,080,000
16 AMLX AMYLYX PHARMACEUTICALS INC Since 2026-07-07 03237H101 Equity (Common)
0.40%
 $11.44 715,000
17 BIIB BIOGEN INC Since 2026-07-07 09062X103 Equity (Common)
0.18%
 $5.30 28,000
18 MIRM MIRUM PHARMACEUTICALS INC Since 2026-07-07 604749101 Equity (Common)
0.34%
 $9.73 100,000
19 ORKA ORUKA THERAPEUTICS INC Since 2026-07-07 687604108 Equity (Common)
1.00%
 $29.01 424,000
20 LFST LIFESTANCE HEALTH GROUP INC Since 2026-07-07 53228F101 Equity (Common)
0.66%
 $18.93 2,500,000
21 TXG 10X GENOMICS INC Since 2026-07-07 88025U109 Equity (Common)
0.73%
 $20.95 950,000
22 MBX MBX BIOSCIENCES INC Since 2026-07-07 55287L101 Equity (Common)
0.31%
 $9.07 300,000
23 ALMS ALUMIS INC Since 2026-07-07 022307102 Equity (Common)
0.13%
 $3.72 150,700
24 RPRX ROYALTY PHARMA PLC Since 2026-07-07 N/A Equity (Common)
1.02%
 $29.55 590,000
25 KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL PLC Since 2026-07-07 N/A Equity (Common)
0.75%
 $21.51 400,000
26 GH GUARDANT HEALTH INC Since 2026-07-07 40131M109 Equity (Common)
0.63%
 $18.29 210,000
27 TYRA TYRA BIOSCIENCES INC Since 2026-07-07 90240B106 Equity (Common)
0.17%
 $4.87 140,000
28 IMNM IMMUNOME INC Since 2026-07-07 45257U108 Equity (Common)
0.03%
 $0.78 33,871
29 ELV ELEVANCE HEALTH INC Since 2026-07-07 036752103 Equity (Common)
0.27%
 $7.91 21,000
30 ELVN ENLIVEN THERAPEUTICS INC Since 2026-07-07 29337E102 Equity (Common)
0.83%
 $23.91 580,000
31 WAY WAYSTAR HOLDING CORP Since 2026-07-07 946784105 Equity (Common)
0.40%
 $11.54 540,000
32 RLAY RELAY THERAPEUTICS INC Since 2026-07-07 75943R102 Equity (Common)
0.22%
 $6.48 500,000
33 VCYT VERACYTE INC Since 2026-07-07 92337F107 Equity (Common)
0.76%
 $22.06 670,000
34 RVMD REVOLUTION MEDICINES INC Since 2026-07-07 76155X100 Equity (Common)
0.50%
 $14.41 100,000
35 PCSC PERCEPTIVE CAPITAL SOLUTIONS CORP Since 2026-07-07 N/A Equity (Common)
0.06%
 $1.69 169,200
36 PCVX VAXCYTE INC Since 2026-07-07 92243G108 Equity (Common)
1.07%
 $30.91 540,000
37 MRNA MODERNA INC Since 2026-07-07 60770K107 Equity (Common)
1.21%
 $34.91 760,000
38 VRDN VIRIDIAN THERAPEUTICS INC Since 2026-07-07 92790C104 Equity (Common)
0.40%
 $11.59 860,000
39 VTRS VIATRIS INC Since 2026-07-07 92556V106 Equity (Common)
0.95%
 $27.41 1,834,609
40 SYRE SPYRE THERAPEUTICS INC Since 2026-07-07 00773J202 Equity (Common)
1.06%
 $30.52 410,000
41 OM OUTSET MEDICAL INC Since 2026-07-07 690145206 Equity (Common)
0.12%
 $3.42 800,000
42 MLYS MINERALYS THERAPEUTICS INC Since 2026-07-07 603170101 Equity (Common)
0.55%
 $15.99 600,000
43 SMMT SUMMIT THERAPEUTICS INC Since 2026-07-07 86627T108 Equity (Common)
0.30%
 $8.58 400,000
44 ANNX ANNEXON INC Since 2026-07-07 03589W102 Equity (Common)
0.15%
 $4.40 750,000
45 ROIV ROIVANT SCIENCES LTD Since 2026-07-07 N/A Equity (Common)
0.63%
 $18.26 640,000
46 JBIO JADE BIOSCIENCES INC Since 2026-07-07 008064206 Equity (Common)
0.24%
 $6.83 280,000
47 ISRG INTUITIVE SURGICAL INC Since 2026-07-07 46120E602 Equity (Common)
0.69%
 $19.91 43,500
48 ASND ASCENDIS PHARMA A/S Since 2026-07-07 N/A Equity (Common)
2.70%
 $77.99 340,000
49 ABOS ACUMEN PHARMACEUTICALS INC Since 2026-07-07 00509G209 Equity (Common)
0.01%
 $0.20 84,427
50 NTRA NATERA INC Since 2026-07-07 632307104 Equity (Common)
0.90%
 $25.98 126,000
51 CTMX CYTOMX THERAPEUTICS INC Since 2026-07-07 23284F105 Equity (Common)
0.37%
 $10.55 2,500,000
52 ZBIO ZENAS BIOPHARMA INC Since 2026-07-07 N/A Equity (Common)
0.08%
 $2.36 122,099
53 MDLN MEDLINE INC Since 2026-07-07 58507V107 Equity (Common)
0.96%
 $27.57 620,000
54 STOK STOKE THERAPEUTICS INC Since 2026-07-07 86150R107 Equity (Common)
0.37%
 $10.80 330,000
55 ALNY ALNYLAM PHARMACEUTICALS INC Since 2026-07-07 02043Q107 Equity (Common)
2.44%
 $70.56 228,000
56 ZBIO ZENAS BIOPHARMA INC Since 2026-07-07 98937L105 Equity (Common)
0.33%
 $9.66 500,000
57 KYMR KYMERA THERAPEUTICS INC Since 2026-07-07 501575104 Equity (Common)
0.63%
 $18.24 225,000
58 CAI CARIS LIFE SCIENCES INC Since 2026-07-07 142152107 Equity (Common)
1.18%
 $34.20 1,800,000
59 XENE XENON PHARMACEUTICALS INC Since 2026-07-07 98420N105 Equity (Common)
1.16%
 $33.62 600,000
60 TVTX TRAVERE THERAPEUTICS INC Since 2026-07-07 89422G107 Equity (Common)
0.42%
 $12.21 290,000
61 OLMA OLEMA PHARMACEUTICALS INC Since 2026-07-07 68062P106 Equity (Common)
0.37%
 $10.81 750,000
62 COGT COGENT BIOSCIENCES INC Since 2026-07-07 19240Q201 Equity (Common)
1.19%
 $34.36 960,000
63 CGON CG ONCOLOGY INC Since 2026-07-07 156944100 Equity (Common)
0.65%
 $18.69 280,000
64 BTSG BRIGHTSPRING HEALTH SERVICES INC Since 2026-07-07 10950A106 Equity (Common)
1.66%
 $47.97 1,000,000
65 CYCN CYCLERION THERAPEUTICS INC Since 2026-07-07 23255M204 Equity (Common)
0.00%
 $0.01 1,500
66 OCUL OCULAR THERAPEUTIX INC Since 2026-07-07 67576A100 Equity (Common)
0.09%
 $2.60 277,371
67 HTFL HEARTFLOW INC Since 2026-07-07 42238D107 Equity (Common)
0.52%
 $14.88 500,000
68 GILD GILEAD SCIENCES INC Since 2026-07-07 375558103 Equity (Common)
2.27%
 $65.42 500,000
69 VKTX VIKING THERAPEUTICS INC Since 2026-07-07 92686J106 Equity (Common)
0.30%
 $8.73 280,000
70 APGE APOGEE THERAPEUTICS INC Since 2026-07-07 03770N101 Equity (Common)
0.16%
 $4.58 55,316
71 COR CENCORA INC Since 2026-07-07 03073E105 Equity (Common)
1.53%
 $44.20 143,500
72 JAZZ JAZZ PHARMACEUTICALS PLC Since 2026-07-07 N/A Equity (Common)
0.70%
 $20.30 100,000
73 NUVL NUVALENT INC Since 2026-07-07 670703107 Equity (Common)
1.25%
 $36.10 360,000
74 CTNM CONTINEUM THERAPEUTICS INC Since 2026-07-07 21217B100 Equity (Common)
0.12%
 $3.59 280,000
Frequently Asked Questions — FIDELITY ADVISOR SERIES VII
What type of mutual fund is FIDELITY ADVISOR SERIES VII?
FIDELITY ADVISOR SERIES VII is a SEC-registered Equity fund, with $2.9B in assets under management. Equity funds invest primarily in a diversified portfolio of stocks and equities, aiming for long-term capital appreciation. They carry higher market risk than bond or money market funds but historically offer stronger long-term returns. Equity mutual funds can be further classified as large-cap, mid-cap, small-cap, growth, value, or sector-specific depending on their investment mandate. As of its latest SEC N-PORT filing, FIDELITY ADVISOR SERIES VII holds 74 portfolio positions, all detailed in the holdings table on this page.
What are FIDELITY ADVISOR SERIES VII's assets under management (AUM)?
FIDELITY ADVISOR SERIES VII has $2.9B in assets under management (AUM) according to its most recent SEC N-PORT filing on StockSifting. AUM represents the total market value of all securities and other assets held by the fund as of the report date. A larger AUM generally signals a more established fund with greater institutional adoption, more trading liquidity, and potentially lower per-unit operational costs due to economies of scale. AUM changes daily as market prices fluctuate and as investors purchase or redeem fund shares — the figure shown here reflects the most recently available N-PORT disclosure, not the current real-time value. For the live figure, consult the fund's official website or its latest SEC EDGAR filing.
What are FIDELITY ADVISOR SERIES VII's top holdings?
According to FIDELITY ADVISOR SERIES VII's most recent SEC N-PORT filing, the fund's largest holdings by portfolio weight include UPSTREAM BIO INC, THERMO FISHER SCIENTIFIC INC, SHOULDER INNOVATIONS INC , among others. The complete list of all 74 holdings — including CUSIP, asset type, portfolio weight percentage, dollar value, and share quantity — is available in the holdings table above. Holdings data is sourced directly from SEC EDGAR N-PORT filings and reflects the fund's positions as of the report date shown at the top of this page. Due to the 60-day SEC disclosure lag, these positions may differ from the fund's current portfolio. For the latest holdings before public release, refer to SEC EDGAR directly.
What is FIDELITY ADVISOR SERIES VII's expense ratio?
Expense ratio data for FIDELITY ADVISOR SERIES VII is not currently available in StockSifting's database. The expense ratio is the annual fee charged by a mutual fund as a percentage of your investment, covering management fees and operational costs. It is one of the most important factors affecting net long-term returns — lower expense ratios allow more of a fund's gross performance to flow through to investors. For the most accurate and current expense ratio, refer to the fund's official prospectus or its SEC EDGAR filings. You can also contact us if you believe this data should be present.
Where can I find FIDELITY ADVISOR SERIES VII's SEC filings?
FIDELITY ADVISOR SERIES VII is required to file monthly portfolio reports (Form N-PORT) with the U.S. Securities and Exchange Commission (SEC). Its SEC Central Index Key (CIK) is 0000315700. You can access all of FIDELITY ADVISOR SERIES VII's SEC filings — including N-PORT holdings disclosures, annual reports (Form N-CEN), and registration statements — directly on SEC EDGAR (CIK: 0000315700). N-PORT filings disclose the fund's complete portfolio holdings, fair value measurements, and certain risk metrics as of each filing period end date. StockSifting automatically parses these filings to populate the holdings table, AUM figures, and expense ratio displayed on this page, making the raw EDGAR data accessible without needing to download and parse XML files manually.
How current is FIDELITY ADVISOR SERIES VII's holdings data on StockSifting?
Holdings data for FIDELITY ADVISOR SERIES VII on StockSifting is sourced from its most recent SEC EDGAR N-PORT filing. Under SEC rules, registered investment companies must file N-PORT reports monthly, but these are made publicly available approximately 60 days after the reporting period end date. This means the holdings shown on this page reflect the fund's portfolio from roughly two months prior — not today's exact positions. The Report date displayed at the top of this page indicates exactly when the underlying data was current. If the fund has made significant portfolio changes since that date — responding to market events, earnings releases, or macro shifts — those changes will not be reflected here until the next N-PORT filing is released. For the most up-to-date holdings before the public disclosure window, refer to the fund's official website or SEC EDGAR directly. StockSifting is best used for fundamental research and historical portfolio analysis, not real-time trading decisions.